Phenylhydrazones are active against non-replicatingMycobacterium tuberculosis

preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Phenylhydrazone compounds showed activity against non-replicating *Mycobacterium tuberculosis*, with two compounds exhibiting enhanced activity under hypoxia and faster kill rates against nutrient-starved bacilli.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

There is an urgent need for the development of shorter, simpler and more tolerable drugs to treat antibiotic tolerant populations of Mycobacterium tuberculosis . We previously identified a series of phenylhydrazones (PHY) active against M. tuberculosis . We selected six representative compounds for further analysis. All compounds were active against non-replicating M. tuberculosis , with two compounds demonstrating greater activity under hypoxic conditions than aerobic culture. Compounds had bactericidal activity with MBC/MIC of <4 and demonstrated an inoculum-dependent effect against aerobically replicating bacteria. Bacterial kill kinetics demonstrated a faster rate of kill against non-replicating bacilli generated by nutrient starvation. Compounds had limited activity against other bacterial species. In conclusion, we have demonstrated that the PHY compounds have some attractive properties in terms of their anti-tubercular activity.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0